On June 11, the Board of Directors of the World Bank approved the Sahel Malaria and Neglected Tropical Diseases, involving a total of $121 million. These funds are split between Burkina Faso ($37 million), Mali ($37 million), Niger ($37 million), and ECOWAS ($10 million).
The goal of the project is to increase access to and use of harmonized community-level services for the prevention and treatment of malaria and selected neglected tropical diseases in targeted cross-borders areas in participating countries in the Sahel region.
These goals are to be achieved through the following three components:
- Improve regional collaboration for stronger results across participating countries ($26.5 million);
Support coordinated implementation of technical strategies and interventions ($74.1 million);
Strengthen institutional capacity to coordinate and monitor implementation ($20.4 million).
An example of an action undertaken in this project is the regional pooling of procurement of Amodiaquine + Sufadoxine – Pyrimethamine (AQ+SP) drugs for SMC to facilitate the timely delivery of these drugs to all three countries in advance of the annual malaria transmission season.
A full overview of procurement guidelines can be found from page 34 onwards of the Project Appraisal Document (PAD). All other relevant information and documents can be found on the World Bank’s project website.